Showing results (321-330 of 527) with videos related to

Sort By:
Pageof 53
Journal for Immunotherapy of Cancer|September 4, 2021
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancerCarmine Carbone, Geny Piro, Antonio Agostini, et al.
Immunotherapy|June 4, 2019
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: a systematic review and meta-analysisAntonio Rossi, Vincenzo Di Noia, Anastasios Gkountakos, et al.
Therapeutic Advances in Medical Oncology|June 7, 2023
Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trialsLuca Mastrantoni, Giovanna Garufi, Elena Di Monte, et al.
Clinical Breast Cancer|July 19, 2014
Human epidermal growth factor receptor 2-positive breast cancer: heat shock protein 90 overexpression, Ki67 proliferative index, and topoisomerase II-α co-amplification as predictors of pathologic complete response to neoadjuvant chemotherapy with trastuzumab and docetaxelEmilio Bria, Jenny Furlanetto, Luisa Carbognin, et al.
Cancer Treatment Reviews|June 1, 2014
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trialsEmilio Bria, Luisa Carbognin, Jenny Furlanetto, et al.
Biomedicines|October 27, 2022
Interleukin-8 in Colorectal Cancer: A Systematic Review and Meta-Analysis of Its Potential Role as a Prognostic BiomarkerChiara Bazzichetto, Michele Milella, Ilaria Zampiva, et al.
Targeted Oncology|September 1, 2018
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate CancerRoberto Iacovelli, Chiara Ciccarese, Claudia Mosillo, et al.
Cancers|June 10, 2022
External Validation of a Prognostic Score for Survival in Lung CarcinoidsMarco Chiappetta, Diomira Tabacco, Carolina Sassorossi, et al.
Cancer Immunology, Immunotherapy : CII|June 9, 2019
Pembrolizumab as first-line treatment for metastatic uveal melanomaErnesto Rossi, Monica Maria Pagliara, Daniela Orteschi, et al.
Frontiers in Oncology|September 27, 2021
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic AdenocarcinomaIlaria Trestini, Luisa Carbognin, Umberto Peretti, et al.
Pageof 53